GAMMA Investing’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
DLA
FIM
CAM
SIS
AB
WPC
FFA
EB
VCM
GAMMA Investing's OGN Position: Q3 2026 in Review
GAMMA Investing increased its Organon & Co (OGN) stake by 38% in Q3 2026, buying an estimated $30.1K and bringing the position to 7,990 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #1818.
GAMMA Investing first reported a position in OGN in Q4 2023 and has held it in 12 quarters since. The position peaked at $122K in Q3 2024. 37 funds tracked by Wall St. Rank hold OGN as of Q3 2026.
- GAMMA Investing held 7,990 shares of Organon & Co worth $109K as of Q3 2026.
- GAMMA Investing bought 2,208 Organon & Co shares in Q3 2026, an estimated $30.1K.
- Organon & Co made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #1818 holding.
- GAMMA Investing first reported a position in Organon & Co in Q4 2023 and has held it in 12 quarters since.
- GAMMA Investing's Organon & Co position peaked at $122K in Q3 2024.
- 37 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.
Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.